Skip to content

The Use of Functional Electrical Stimulation in Conjunction With Respiratory Muscle Training to Improve Unaided Cough in Individuals With Acute Spinal Cord Injury

The Use of Functional Electrical Stimulation in Conjunction With Respiratory Muscle Training to Improve Unaided Cough in Individuals With Acute Spinal Cord Injury

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05745298
Acronym
AFES and RMT
Enrollment
50
Registered
2023-02-27
Start date
2023-07-21
Completion date
2028-09-21
Last updated
2026-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Spinal Cord Injury

Brief summary

The overall objective of this study is to improve unaided cough with abdominal and latissimus dorsi functional electrical stimulation in conjunction with respiratory muscle training in individuals with acute spinal cord injuries.

Interventions

DEVICEXcite Clinical Station

The abdominal functional electrical stimulation (AFES) will be conducted using the Xcite system. This is a battery-powered stimulator with up to 12 channels of cyclical stimulation. It is a task-specific modality to enhance mass practice during neurological re-education. The electrical stimulation will be applied to the abdominal and back muscles. In addition, participants will receive two specific respiratory muscle training exercises performed 3 days per week.

Sponsors

University of Miami
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Traumatic and atraumatic C2- T12 Spinal cord injury (AIS A, B, and C motor incomplete and complete injuries) currently admitted to inpatient rehabilitation with an injury date \< 12 months prior to enrollment 2. Positive response to electrical stimulation through a palpable contraction 3. Fluent in written and spoken English

Exclusion criteria

1. Individuals who do not meet inclusion criteria 2. Prisoners 3. Concurrent traumatic brain injury determined by Rancho level of cognitive functioning \< VI 4. Individuals with open tracheostomy 5. Persons with pacemakers 6. Pregnant women 7. Persons with epilepsy 8. Open wounds or metal implants at site of electrode placement 9. Unresponsive to functional electrical stimulation 10. Current diagnosis or history of thoraco-abdomino-pelvic cancer

Design outcomes

Primary

MeasureTime frameDescription
Percentage change in peak cough flow (PCF)one week pre-intervention and up to 4 weeks post-interventionAssessing the percentage change in peak cough flow as assessed by peak expiratory flow meter with a pillow face mask.
Percentage change in peak expiratory flowone week pre-intervention and up to 4 weeks post-interventionAssessing the percentage change in peak expiratory flow as assessed by peak expiratory flow meter with a pillow face mask.

Secondary

MeasureTime frameDescription
Percentage change in forced expiratory volume in 1 second (FEV1)one week pre-intervention and up to 4 weeks post-interventionAssessing the percentage change in forced expiratory volume in 1 second (FEV1) as measured by the spirobank II. Measured in Liters/minute.
Percentage change in forced vital capacity (FVC)one week pre-intervention and up to 4 weeks post-interventionAssessing the percentage change in forced vital capacity (FVC) as measured by the spirobank II. Measured in Liters/minute.
Percentage change in maximum inspiratory pressure (MIP)one week pre-intervention and up to 4 weeks post-interventionAssessing the percentage change in maximum inspiratory pressure (MIP) as measured by the MicroSpiro. Measured in Liters/minute.
Percentage change in maximum expiratory pressure (MEP)one week pre-intervention and up to 4 weeks post-interventionAssessing the percentage change in maximum expiratory pressure (MEP) as measured by the MicroSpiro. Measured in Liters/minute.
Change in cough effectiveness as measured by Likert Scaleone week pre-intervention and up to 4 weeks post-interventionThe 5-point Likert scale will be used to obtain a self-rated perception of cough effectiveness. The participant will be asked to rate how strong and how well secretions were cleared after coughing. The rating scale will range from 1=very poor; 2=poor; 3=fair, 4=good; 5= very good. A score of 4 or 5 is classified as effectively clearing secretions after coughing.

Countries

United States

Contacts

CONTACTGary J Farkas, PhD
gjf50@med.miami.edu305-243-4518
PRINCIPAL_INVESTIGATORStephane Philippe-Ratway, MS, CCC-SLP

University of Miami

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 18, 2026